(Q35126758)

6 August 2017

Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens (English)

1 reference

6 August 2017

1 reference

1 reference

7

Per Eystein Lønning

1 reference

6 August 2017

8

Stian Knappskog

1 reference

6 August 2017

3

Jon-Helge Angelsen

1 reference

6 August 2017

1

Inger Marie Løes

1 reference

6 August 2017

4

Arild Horn

1 reference

6 August 2017

5

Jürgen Geisler

1 reference

6 August 2017

Heike Immervoll

2

1 reference

PubMed ID

25318602

6 August 2017

Christian Busch

series ordinal

6

1 reference

6 August 2017

16 October 2014

1 reference

6 August 2017

1 reference

6 August 2017

36

1 reference

6 August 2017

2

1 reference

6 August 2017

1003-1013

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

start time

16 October 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s13277-014-2711-5

0 references

cites work

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Mutation-specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Comparison of allelic discrimination by dHPLC, HRM, and TaqMan in the detection of BRAF mutation V600E.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Mutations of the BRAF gene in human cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342512

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

28 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2711-5

BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25318602

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25318602

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2711-5

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

PubMed ID

25318602